Item(by='jszymborski', descendants=None, kids=None, score=None, time=1610466878, title=None, item_type='comment', url=None, parent=25741972, text='Clearly Flu, HIV, and Nipah are more pressing, but I found myself wondering last night what the odds are of a rhinovirus vaccine being in the cards thanks to rapid progress SARS-CoV-2 has pressed us to make w.r.t. RNA and protein-like vaccines.<p>Economics is the largest barrier in my mind. While my understanding is that these vaccines are less expensive to produce, it&#x27;s hard to convince people to get the flu shot, let alone a common cold shot. What&#x27;s more is that with hundreds of variants, it&#x27;s efficacy would be hard to get right.<p>That said, I&#x27;d gladly pay a heft amount yearly if it meant I had a &gt;60% chance of not catching a cold that year.')